Recruiting
A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
NCT05341557
- Conditions
- Advanced Solid Tumor, HCC, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Chaoyang, Beijing Municipality, China
- Cangzhou Central Hospital Cangzhou, Hebei, China
- Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China
- Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China